Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Moving-average based index to timely evaluate the current epidemic situation after COVID-19 outbreak

View ORCID ProfileHe Yun-ting, Wang Xiao-jin, He Hao, Zhai Jing, View ORCID ProfileWang Bing-shun
doi: https://doi.org/10.1101/2020.03.24.20027730
He Yun-ting
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for He Yun-ting
Wang Xiao-jin
2Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
He Hao
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhai Jing
1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
2Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wang Bing-shun
2Department of Biostatistics, Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wang Bing-shun
  • For correspondence: wangbingshun@sjtu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

[ABSTRACT]

A pneumonia outbreak caused by a novel coronavirus (COVID-19) occurred in Wuhan, China at the end of 2019 and then spread rapidly to the whole country. A total of 81,498 laboratory-confirmed cases, including 3,267 deaths (4.0%) had been reported in China by March 22, 2020, meanwhile, 210,644 laboratory-confirmed cases and 9,517 deaths (4.5%) were reported outside China. Common symptoms of COVID-19 pneumonia included fever, fatigue and dry cough. In face of such a sudden outbreak of emerging novel infectious diseases, we have no history to learn from and no evidence to count on. Traditional models often predict inconsistent results. There is an urgent need to establish a practical data-driven method to predict the evolutionary trend of the epidemic, track and prejudge the current epidemic situation after the COVID-19 outbreak. Here we propose a simple, directly and generally applicable index and we name it ‘epidemic evaluation index’ (EEI), which is constructed by 7-day moving average of the log-transformed daily new cases (LMA). EEI could be used to support the decision-making process and epidemic prevention and control strategies through the evaluation of the current epidemic situation. First, we used SARS epidemic data from Hong Kong in 2003 to verify the practicability of the new index, which shows that the index is acceptable. The EEI was then applied to the COVID-19 epidemic situation analysis. We found that the trend direction of different districts in China changed on different date during the epidemic. At the national level and at local Hubei Province level, the epidemic both peaked on February 9. While the peak occurred relatively earlier, i.e. on February 5 in other provinces. It demonstrated the effectiveness of decisive action and implementations of control measures made by Chinese governments. While local governments should adjust management measures based on local epidemic situation. Although the epidemic has eased since late February, continued efforts in epidemic control are still required to prevent transmission of imported cases in China. However, the global COVID-19 epidemic outside China continues to expand as indicated by the EEI we proposed. Currently, efforts have been made worldwide to combat the novel coronavirus pandemic. People all over the world should work together and governments of all countries should take efficient measures in the light of Chinas experience and according to national circumstances and local conditions.

  • Novel Coronavirus Disease 2019 (COVID-19)
  • moving average
  • epidemic evaluation

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data generated or used during the study are available on the official website and an appendix of a public research.

http://2019ncov.chinacdc.cn/2019-nCoV/

http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 26, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Moving-average based index to timely evaluate the current epidemic situation after COVID-19 outbreak
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Moving-average based index to timely evaluate the current epidemic situation after COVID-19 outbreak
He Yun-ting, Wang Xiao-jin, He Hao, Zhai Jing, Wang Bing-shun
medRxiv 2020.03.24.20027730; doi: https://doi.org/10.1101/2020.03.24.20027730
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Moving-average based index to timely evaluate the current epidemic situation after COVID-19 outbreak
He Yun-ting, Wang Xiao-jin, He Hao, Zhai Jing, Wang Bing-shun
medRxiv 2020.03.24.20027730; doi: https://doi.org/10.1101/2020.03.24.20027730

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8783)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1861)
  • Geriatric Medicine (178)
  • Health Economics (388)
  • Health Informatics (1290)
  • Health Policy (644)
  • Health Systems and Quality Improvement (491)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10557)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1754)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (342)
  • Occupational and Environmental Health (461)
  • Oncology (964)
  • Ophthalmology (282)
  • Orthopedics (107)
  • Otolaryngology (176)
  • Pain Medicine (117)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (264)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1843)
  • Public and Global Health (3982)
  • Radiology and Imaging (654)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)